The Ministry of Health recorded 4,892 new COVID-19 cases in Vietnam on Thursday, alongside 1,649 recoveries and 54 deaths.
The latest cases, including 16 imported and 4,876 local infections, were reported in 49 provinces and cities, the health ministry said, elucidating that 1,980 patients were detected in the community.
Ho Chi Minh City registered 1,069 of the domestically-infected cases, Dong Nai Province 745, Binh Duong Province 618, An Giang Province 286, Tay Ninh Province 190, Ha Giang Province 184, Kien Giang Province 160, Tien Giang Province 139, Can Tho City 138, Quang Nam Province 129, Soc Trang Province 128, Binh Thuan Province 116, Hanoi 31, Khanh Hoa Province 30, Ba Ria-Vung Tau Province 19, and Da Nang four.
Vietnam had confirmed 3,592 locally-acquired infections on Wednesday.
The Southeast Asian country has documented 900,669 community transmissions in 62 out of its 63 provinces and cities since the fourth virus wave emerged on April 27, 811,146 of them having recovered from the respiratory disease.
Ho Chi Minh City is the biggest hotbed with 429,082 patients, followed by Binh Duong Province with 231,024, Dong Nai Province with 63,715, Long An Province with 34,468, Tien Giang Province with 16,124, Dong Thap Province with 9,551, Khanh Hoa Province with 8,917, Da Nang with 4,963, Ba Ria-Vung Tau Province with 4,603, and Hanoi with 4,496.
Vietnam detected only 1,570 locally-transmitted infections in total in the previous three waves.
The health ministry announced 1,649 recoveries on Thursday, bringing the total to 813,963.
The toll has risen to 21,910 deaths after the ministry confirmed 54 fatalities on the same day, including 25 in Ho Chi Minh City and six in Binh Duong Province.
Vietnam has found 905,477 infections since the COVID-19 pandemic first hit it early last year.
Health workers have administered over 77 million vaccine doses, including 1,170,967 shots on Wednesday, since vaccination was rolled out on March 8.
More than 22.6 million people have been fully inoculated.
Health authorities target to inoculate at least two-thirds of a population of nearly 98 million people against COVID-19 by the first quarter of next year.